NERV

Minerva Neurosciences, Inc.

1 day chart

About NERV

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company's lead product candidates are roluperidone (MIN-101) and MIN-301. Roluperidone (MIN-101) is a compound that blocks serotonin, sigma, and α adrenergic receptors that are involved in the regulation of mood, cognition, sleep, and anxiety. The Company is developing roluperidone to treat patients with schizophrenia. Roluperidone is designed to block a specific subtype of serotonin receptor called 5-HT2A. The Company’s MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1), protein, for the treatment of Parkinson’s disease and for other neurodegenerative disorders. The Company is also developing seltorexant for the treatment of insomnia disorder and adjunctive treatment of the major depressive disorder (MDD).

Buy US stocks in Australia starting with NERV. Open an account and start investing today!

Market Capitalisation

$51.33M

Price-earnings ratio

Dividend yield

0.00%

Volume

8.68K

High today

$7.39

Low today

$7.15

Open price

$7.36

52-week high

$14.70

52-week low

$1.26

NERV FAQs

Can I buy NERV shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy NERV shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Minerva Neurosciences, Inc.?

One share of Minerva Neurosciences, Inc. is valued at $8.90.

What is the ticker symbol for Minerva Neurosciences, Inc.?

The ticker symbol for Minerva Neurosciences, Inc. is NERV.

How do I buy NERV shares in Australia?

To buy NERV stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in NERV

What is the 52-week high for Minerva Neurosciences, Inc. stock?

The Minerva Neurosciences, Inc. 52-week high stock price is $14.70.

What is the 52-week low for Minerva Neurosciences, Inc. stock?

The Minerva Neurosciences, Inc. 52-week low stock price is $1.26.

What is the market capitalisation of Minerva Neurosciences, Inc. NERV?

As of 28/09/2023 Minerva Neurosciences, Inc. has a market cap of $51M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.